Levis Jeans With A Belt

list medications that are monitored by Afssaps

The French Agency for Safety of Health Products (AFSSAPS) make public a list of 75 drugs and 12 drug families under enhanced In the wake of the controversy about the Mediator. These molecules will be investigated pharmacovigilance, but patients who have been prescribed one of these drugs should "under no circumstances stop without consulting a pharmacist or doctor."

Pain killers containing dextropropoxyphene (Di-antalvic, Propofan and generics) will be a withdrawal of authorization for the market March 1.

another example, the Noctran (sleep disorders), and covers three active "trivial", is being considered a proposal to withdraw in March. Similarly, the Buflomedil, a vasodilator, will disappear very soon pharmacies. The Buflomedil is marketed under the name of the firm Fonzylane by Cephalon and as generic firms with Sandoz, Mylan and Biogaran, a subsidiary of Servier.

The list of 75 drugs:

Actos (diabetes) , Alli, Arcoxia, Arixtra, patent blue V, Byetta (diabetes), Celance, Cervarix, Chantix (smoking cessation), Cimzia, Colokite, Cymbalta (depression), Diantalvic, Efient, Elaone, Equanil (alcohol withdrawal), Exjade, CosmoFer , Fonzylane, Galvus, Eucreas, Gardasil, Gliven, Hexaquine, Intrensa, Isentress, Ianumet, Ianuvia, Ketum, Levothyrox, Lipiocis, Lyrica, Mepronizine (insomnia), methadone, Ritalin, Mynocine, Multaq, Nexen, Noctran (sleep), Ongliza , Orienca, Parlodel, Pedea, Pholcodine (cough), pradaxa, praxinor (hypotension), Prevenar, Primalan, Procoralan Protelos, Protopic, Revlimid, Rivotril, Roacterma, Rohypnol (sleep), Soriatane, Stablon (Depression), Stelara, stilnox, Subutex, Thalidomide Celgene Toctino, Tramadol, Trivastal, Tysabri (MS), Valdoxan Vastarel, Vfend, Victoza, Xarelto, Xyrem, ZYPADHERA, Zyban (smoking cessation), Zyvox.


ladepeche.fr